期刊文献+

甘精胰岛素治疗门诊2型糖尿病的疗效观察

下载PDF
导出
摘要 目的探讨甘精胰岛素治疗门诊2型糖尿病中的临床疗效与安全性。方法选择口服降糖药血糖仍不能达标的门诊2型糖尿病患者68例,随机等分成两组。在原方案不变的情况下,一组联合使用甘精胰岛素,另一组联合使用中性鱼精蛋白锌人胰岛素作为对照。治疗3个月后,观察治疗前后空腹血糖(FBG)、餐后2h血糖(2hPG)和糖化血红蛋白(HbA1c)的变化,并统计低血糖事件的发生率。结果治疗3个月后,两组患者FBG、2hPG、HbA1c较治疗前均显著降低;体重指数无明显变化;观察组低血糖事件发生率明显低于对照组(P<0.05);两组间治疗前后血糖无统计学差异(P>0.05)。结论甘精胰岛素联合其他口服降糖药能迅速、有效地控制血糖,低血糖发生率低,操作方便,无需住院,病人容易接受,依从性好,值得临床推广。
作者 毛有可
出处 《海峡药学》 2012年第10期211-212,共2页 Strait Pharmaceutical Journal
  • 相关文献

参考文献3

  • 1陈颖珠.实用内科学[M].第十二版.北京人民卫生出版社,2005:1005.
  • 2姜文淸,杨丽萍,马捷,等.长效基础胰岛素类似物甘精胰岛素[J].中国新药杂志,2004,5(12):39.
  • 3杨昱,王昆,刘超.糖尿病基础胰岛素治疗[J].中国实用内科杂志,2010,30(10):939-941. 被引量:20

二级参考文献13

  • 1Porcellati F, Rossetti P, Busciantella NR, et al. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes[J]. Diabetes Care, 2007, ( 30 ) :2447 - 2452.
  • 2Miles HL, Acerini CL. Insulin analog preparations and their use in children and adolescents with type 1 diabetes mellitus [ J ]. Pediatr Drugs,2008,10 (3) :163 -176.
  • 3Crasto W,Jarvis J, Khunti K, et al. New insulins and new insulin regimens:a review of their role in improving glycaemic control in patients with diabetes [ J ]. Postgrad Med J,2009,85:257 - 267.
  • 4Rosenstock J, Davies M, Home PD, et al. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulinnaive people with type 2 diabetes [ J ]. Diabetologia, 2008 ( 51 ) : 408 -416.
  • 5Rossetti P, Pampanelli S, Fanelli C,et al. Intesive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime[J]. Diabetes care,2003,26:1490 - 1496.
  • 6Peterson GE. Inter mediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir [ J ]. Curt Med Res Opin,2006,22 (12) :2613 - 2619.
  • 7Riddle MC, Rosenstock J, Gerieh J, et al. The treat-to-target trial, randomized addition of glargine or human NPH insulin ro oral therapy of type 2 diabetic patients [ J ]. Diabetes Care, 2003 (26) :3080-3086.
  • 8Vague P,Selam JL, Skeie S, et al. Insulin determir is associated with more predictable glycemJc control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart [ J ]. Diabetes Care,2003 (26) :590-596.
  • 9Johnson CK. When a unit of insulin is not a unit:Determir dosing and insulin cost in type 2 diabetes mellitus [ J ]. Insulin, 2009,4: 87 - 93.
  • 10Soliman AT, Omar M, Rizk MM, et al.Glycaemic control with modified intensive insulin injuctions (MII) using insulin pens and premixed insulin in children with type 1 diabetes:a randomized controlled trial [ J 1. J Trop Pediatr, 2006,52:276 - 281.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部